“Calling All SMA Warriors: FDA and EMA Give Thumbs Up to Boosted Nusinersen Dose! Get the Scoop Here!”
Revolutionizing SMA Treatment: The DEVOTE Study The Potential of Nusinersen’s Higher Dose Regimen Have you heard the buzz about the latest breakthrough in treating Spinal Muscular Atrophy (SMA)? Applications are now being developed based on data from the DEVOTE study, which reveal the exciting potential of an investigational higher dose regimen of nusinersen. For those…